What is the recommended diagnostic workup and management for functional dyspepsia?

Functional Dyspepsia: Diagnostic Workup and Management

For patients presenting with chronic upper abdominal symptoms, diagnose functional dyspepsia clinically when bothersome epigastric pain/burning, early satiation, or postprandial fullness persists for >8 weeks without alarm features, then implement a stepwise treatment algorithm starting with H. pylori testing and eradication if positive, followed by empirical PPI therapy, with tricyclic antidepressants reserved for refractory cases. 1

Diagnostic Approach

Clinical Diagnosis

• Make the diagnosis clinically in patients with bothersome epigastric symptoms (pain, burning, early satiation, postprandial fullness) lasting >8 weeks without alarm features 1
• Most patients (approximately 80%) with dyspepsia will have functional dyspepsia after investigation 1, 2
• Explain to patients that FD is a disorder of gut-brain interaction involving altered nerve sensitivity, not absence of disease 1

When to Perform Endoscopy

Urgent endoscopy is indicated for:

• Age ≥55 years with weight loss 1
• Age >40 years from high gastric cancer risk areas or with family history of gastro-esophageal cancer 1

Non-urgent endoscopy is indicated for:

• Age ≥55 years with treatment-resistant dyspepsia 1
• Age ≥55 years with raised platelet count, nausea, or vomiting 1

Additional imaging:

• Consider urgent abdominal CT in patients ≥60 years with abdominal pain AND weight loss to exclude pancreatic cancer 1

Essential Laboratory Testing

• Full blood count in patients ≥55 years 1
• Celiac serology if overlapping IBS-type symptoms present 1
• H. pylori testing (non-invasive) in all patients without alarm features 1

Tests NOT Recommended Routinely

• Gastric emptying studies 1
• 24-hour pH monitoring 1
• Abdominal ultrasound (per Italian guidelines) 3

Management Algorithm

First-Line Treatment

Step 1: H. pylori Management

• Test all patients for H. pylori using non-invasive methods 1
• If positive: Eradicate with standard therapy (strong recommendation, high-quality evidence) 1
• Confirm eradication only in patients at increased gastric cancer risk 1
• Note: Many H. pylori-positive patients with FD will not gain symptomatic benefit, but this cures underlying ulcer disease 2

Step 2: Empirical Acid Suppression (if H. pylori negative or symptoms persist)

• Prescribe PPIs at standard dose (strong recommendation, high-quality evidence) 1
• Use the lowest effective dose - no dose-response relationship exists 1
• Well tolerated with minimal adverse events 1
• Alternative: H2-receptor antagonists may be effective but evidence is weaker 1

Step 3: Lifestyle Modifications

• Recommend regular aerobic exercise (strong recommendation) 1
• Insufficient evidence for specific dietary therapies including low-FODMAP diets 1
• Avoid overly restrictive diets that may lead to malnutrition 1

Step 4: Prokinetics (Consider for PDS subtype)

• May be efficacious but availability varies by region 1
• Tegaserod has strongest evidence (moderate quality) 1
• Acotiamide, itopride, mosapride have weaker evidence (low quality) 1
• Italian guidelines recommend against first-line use, preferring them for PDS patients specifically 3

Second-Line Treatment (Refractory Cases)

Tricyclic Antidepressants (TCAs) - Primary Second-Line Option

• Start amitriptyline 10 mg once daily at bedtime 1
• Titrate slowly to maximum 30-50 mg daily 1
• Strong recommendation with moderate-quality evidence 1
• Critical counseling point: Explain these are "gut-brain neuromodulators" that reduce nerve hypersensitivity, NOT treatment for depression 1
• Warn about side effects (dry mouth, drowsiness, constipation) 1
• Can be initiated in primary or secondary care 1

Alternative Second-Line Options:

• Sulpiride 100 mg four times daily or levosulpiride 25 mg three times daily 1
• Mirtazapine, particularly for patients with weight loss 3
• Insufficient evidence for SSRIs 3

Management of Severe/Refractory FD

When symptoms persist despite above measures:

1. Involve multidisciplinary team (strong recommendation) 1

   • Gastroenterologist
   • Dietitian (early involvement to prevent restrictive eating) 1
   • Psychologist/behavioral therapist
   • Primary care physician

2. Screen for eating disorders including avoidant restrictive food intake disorder (ARFID) in patients with weight loss and food restriction 1

3. Consider cognitive behavioral therapy for patients not responding to medical therapy 3

4. Avoid iatrogenic harm:

   • Do NOT prescribe opioids (strong recommendation) 1
   • Do NOT refer for surgery (strong recommendation) 1

Key Clinical Pitfalls to Avoid

1. Don't delay diagnosis waiting for 6-month symptom duration - the Rome IV clinical criteria require only 8 weeks of symptoms for practical clinical use 1

2. Don't over-investigate - routine gastric emptying studies and pH monitoring add no value in typical FD 1

3. Don't restrict diet excessively - insufficient evidence for elimination diets, and overly restrictive eating can cause harm 1

4. Don't use high-dose PPIs - no dose-response relationship exists; use lowest effective dose 1

5. Don't forget to explain the diagnosis - establishing empathic doctor-patient relationship and explaining gut-brain interaction reduces healthcare utilization and improves quality of life 1

Referral Indications

Refer to gastroenterology when:

• Diagnostic uncertainty exists 1
• Symptoms are severe or refractory to first-line treatments 1
• Patient requests specialist opinion 1
• Ideally manage in specialist clinic with access to dietetic support and gut-brain behavioral therapies 1